Table 1. Demographics of studied subjects.
Rapid progressors | Slow progressors | ||
---|---|---|---|
Characteristic | (n = 6) | (n = 13) | P |
Age: median (range), yr | 57 (38 – 59) | 57 (38 – 66) | 0.67 |
Race | 5 C; 1 Asian | 10 C; 1 AA; 2 Asian | |
Male / female sex | 5 / 1 | 9 / 4 | |
HCV RNA, median (range), copies × 103 IU/mL | 2,025 (594 – 17,800) | 1,210 (31.5 – 14,600) | 0.80 |
HCV genotype (no.) | 1 (6) | 1 (12), 3 (1) | |
ALT: median (range) | 81 (34 – 101) | 59 (34 – 417) | 0.83 |
Liver Inflammation Grade: median (range) | 1 (1 – 3) | 1 (1 – 2) | 0.47 |
Liver Fibrosis Stage: median (range) | 2 (2 – 4) | 1 (0 – 2) | 0.006 |
Histological activity index (HAI): median (range) | 3 (3 – 5) | 2 (1 – 4) | 0.009 |
Fibrosis progression rate: median (range), Metavir/yr | 0.2 (0.1 – 0.67) | 0.0 (−0.167 – 0.074) | 0.0005 |
Time between 2 biopsies: median (range), yr | 4.9 (3.46 – 5.21) | 4.26 (3.85 – 6.76) | 0.44 |